European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Summary

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, severe alopecia areata. Patients from European sites who previously completed a qualifying CTP-543 clinical trial may participate in this study.

Timeline

Start

2021-10-19

Primary completion

2024-07-18

Completion

2024-07-18

Drugs

Indications